[1] Arbeitsgruppe für pdiatrische Schlafmedizin und Schlafforschung der sterreichischen Gesellschaft für Kinder-und Jugendheilkunde(GKJ).Schnarchen und obstruktives Schlafapnoesyndrom(OSAS)[J]. Mona-tsschrift Kinderheilkunde,2011, 159(7):667
[2] Nural S, Gunay E, Halici B, et al. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome[J]. Inflammation, 2013,36(1): 66
[3] Yamakawa H, Shiomi T, Sasanabe R, et al. Pulmonary hypertension in patients with severe obstructive sleep apnea[J]. Psych Clin Neurosciences, 2002, 56(3): 311
[4] Mermigkis C, Bouloukaki I, Antoniou K M, et al. CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep[J]. Sleep Breath Schlaf Atmung,2013,17(4):1137
[5] Dong Y, Geng Y, Li L, et al. Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice[J]. J Exper Med,2015, 212(2): 235
[6] Li M, Krishnaveni M S, Li C, et al. Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis[J]. Clin Invest,2011,121(1): 277
[7] Nair D, Dayyat E A, Zhang S X, et al. Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea[J]. PloS One,2011, 6(5): e19847
[8] Passali D, Corallo G, Petti A, et al. A comparative study on oxidative stress role in nasal breathing impairment and obstructive sleep apnoea syndrome[J]. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale,2016,36(6): 490
[9] Franklin K A, Lindberg E. Obstructive sleep apnea is a common disorder in the population - a review on the epidemiology of sleep apnea[J]. J Thorac Dis,2015,7(8):1311
[10] Drager L F, Brunoni A R, Jenner R, et al. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials[J]. Thorax,2015,70(3): 258
[11] Hayakawa S, Ohashi K, Shibata R, et al. Association of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy Men[J]. PloS One,2016,11(5): e0153619
[12] Sylva M, Li V S, Buffing A A, et al. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis[J]. PloS one,2011,6(8):e22616
[13] Liu X, Liu Y, Yang Z, et al. Cell type specific expression of Follistatin-like 1 (Fstl1) in mouse embryonic lung development[J]. J Mol Histol,2018
[14] Mattiotti A, Prakash S, Barnett P, et al. Follistatin-like 1 in development and human diseases[J]. CMLS,2018,75(13): 2339
[15] Fang Y, Zhang S, Li X, et al. Follistatin like-1 aggravates silica-induced mouse lung injury[J]. Sci Reports,2017,7(1): 399